Man Group plc - UROGEN PHARMA LTD ownership

UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 65 filers reported holding UROGEN PHARMA LTD in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
Man Group plc ownership history of UROGEN PHARMA LTD
ValueSharesWeighting
Q1 2023$148,542
+17.1%
16,076
+12.4%
0.00%
Q4 2022$126,841
-78.6%
14,300
-13.2%
0.00%
-100.0%
Q2 2019$592,000
-91.0%
16,484
-90.8%
0.00%
-92.0%
Q1 2019$6,612,000
+28.2%
178,996
+49.5%
0.02%
+8.7%
Q4 2018$5,156,000
+2.4%
119,736
+12.4%
0.02%
+27.8%
Q3 2018$5,033,000
+378.9%
106,548
+404.2%
0.02%
+350.0%
Q2 2018$1,051,00021,1320.00%
Other shareholders
UROGEN PHARMA LTD shareholders Q4 2018
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 1,111,050$9,099,0004.23%
GREAT POINT PARTNERS LLC 873,424$7,153,0001.72%
Wildcat Capital Management, LLC 533,139$4,366,0001.45%
Opaleye Management Inc. 238,670$1,955,0000.88%
MENORA MIVTACHIM HOLDINGS LTD. 2,949,489$24,156,0000.44%
Annandale Capital, LLC 84,331$691,0000.27%
Yahav Achim Ve Achayot - Provident Funds Management Co Ltd. 25,330$206,0000.18%
RTW INVESTMENTS, LP 857,464$7,023,0000.18%
Harel Insurance Investments & Financial Services Ltd. 1,025,611$8,400,0000.18%
BENDER ROBERT & ASSOCIATES 41,131$337,0000.13%
View complete list of UROGEN PHARMA LTD shareholders